1. Home /
  2. Fundamental Analysis

Fundamental Analysis

LivePerson's Weak Charts Need Repair

Renewed price strength is not likely for a while.

Jim Cramer: How to Value Apple and Walmart? Think Like the Sellers

You have to be fluid and dynamic, and get in the head of the sellers of these stocks. And then you have to see what they give you.

5 Safe Haven Utilities to Power Up Your Portfolio

Here are 5 favorites in a relatively defensive sector.

Jim Cramer: Being a Tortoise Isn't So Bad in an Age of Rapid, Errant Information

The inaccurate reporting on PepsiCo's earnings shows why it can be costly to react to the rapid-fire news stories that follow a release.

Is the Latest Coronavirus News Just Another Dip Buying Opportunity?

Updates on the virus are causing another pullback. The question is whether this will lead to a deeper pullback or just another chance to buy the dip.

6 Attractive REITs for Growth and Income

These top picks include the REIT redeveloping New York's Penn Station and one that is smack dab in the middle of the 5G revolution.

Jim Cramer: Why Simon Property's Taubman Centers Buy Is So Important

This is a statement buy that is changing the shopping mall narrative, and we need to see one in oil and gas next.

The Market Is Still Complacent on Coronavirus News

The market's resilience in the face of such an ugly threat has many market players trying to find ways to reconcile the movement with the news flow.

This High-Yield Oil Stock Is a Buy

Refiner has now met or exceeded analysts' EPS estimates for 15 quarters in a row, a very impressive streak given the cyclical nature of the oil industry.

The Wisdom of Taking Profits in Small Biotech Stocks Upon FDA Drug Approval

There are multiple reasons why these stocks often decline after their drugs receive the blessing of regulators.